Tenderwize
Retour à la recherche

Open house drug discount agreements Tiotropiumbromide, inhalation solution (Respimat(R)), ATC R03BB04

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Sep 03, 2027 · 370 days left·Open·Supplies·Framework
Inscrivez-vous pour sauvegarderOpen documents
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Tiotropiumbromid, in der Darreichungsform Inhalationslösung (Respimat(R)), ATC R03BB04

60/100

Score d'opportunité

PromisingLow complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

60 / 100

Complexité

30 / 100

Facteurs de risque

Automatic termination of the open house agreement if a nationwide or state-level discount contract for the same active...

Strict submission rules: paper copies must be received by the 10th of the month if a scan is sent earlier; electronic s...

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Aperçu

Strong opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Oct 2027
  • Non-exclusive discount agreements for Tiotropiumbromide inhalation solution (Respimat(R)), ATC R03BB04.
  • Contract duration from 01.11.2025 to 31.10.2027.
Afficher le résumé complet

Open house model for non-exclusive discount agreements with pharmaceutical companies for Tiotropiumbromide inhalation solution. No selection procedure; all eligible companies can join. Contract period 01.11.2025-31.10.2027, with possible earlier termination if a regular discount contract comes into effect. Submission: signed documents in paper or with qualified electronic signature. Only pharmaceutical companies eligible.

Risques

Automatic termination of the open house agreement if a nationwide or state-level discount contract for the same active...

Strict submission rules: paper copies must be received by the 10th of the month if a scan is sent earlier; electronic s...

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Eligibility

  • Only pharmaceutical companies are eligible.

Administrative

  • Submission of signed contract, signed annex 'Festlegung der vertragsgegenständlichen Arzneimittel', and signed declaration of reliability.
  • Documents must be submitted either in paper (2 copies, signed by hand) or electronically with a qualified electronic signature.

Les exigences peuvent être incomplètes.

Critères d'attribution

Lot 1

No award criteria; contracts are offered to all eligible participants.

Acheteur

Localisation

München, DEU

Site web

www.aok.de

Profil acheteur

Ouvrir le profil

Identifiant

DE811695320

Activité

Health

Lots (1)

LOT-0001

Open house drug discount agreements Tiotropiumbromide, inhalation solution (Respimat(R)), ATC R03BB04

Non-exclusive discount agreement for the active ingredient Tiotropiumbromide in inhalation solution (Respimat). All eligible pharmaceutical companies can join. Contract duration 01.11.2025-31.10.2027. Submission of signed contract and declaration of reliability required.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE212, Germany

Durée

Oct 2025 - Oct 2027

Catégorie

Pharmaceutical products

Critères d'attribution

No award criteria; contracts are offered to all eligible participants.

Date limite

Deadline Sep 03, 2027

Détails de la procédure

Date de publication
14 Sep 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
599784-2025

Documents (2)

Document de consultation 1Portail de soumission 1

Appels d'offres similaires

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)

Aug 31

Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta

Aug 30